Skip to content

Madhavi Averneni, MD

NPI 1710171954ActiveIndividual· Internal Medicine, Endocrinology, Diabetes & Metabolism· Greenville, NC

Internal Medicine, Endocrinology, Diabetes & Metabolism (MD) in Greenville, North Carolina, licensed in NC, MO and VA, with an NPI issued in August 2007. Part D covered 95 prescriptions written in 2024, 38% of them generic. Glaxosmithkline, LLC. reported $14.46 in payments in 2025, mostly food and beverage.

Overview

NPI1710171954
StatusActive
Entity typeIndividual
CredentialMD
Sole proprietorNo
NPI issuedAug 30, 2007
Last updated in NPPESJan 30, 2018

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Endocrinology (NC)

Part D prescriptions in 2024

Prescriptions (claims)95 · 150 30-day fills
Patients44
Total drug cost$30,271
Generic share38% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$14.46 · 1 payment from 1 company
  • 2024$98.80 · 5 payments from 5 companies

Top paying companies in 2025

CompanyAmountPayments
Glaxosmithkline, LLC.$14.461

What the 2025 payments were for

  • Food and Beverage$14.46 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Internal Medicine, Endocrinology, Diabetes & Metabolism providers in Greenville

All Internal Medicine, Endocrinology, Diabetes & Metabolism providers in North Carolina →